The peer-reviewed data on recombinant BET is here, and it says that recombinant BET methods are inferior to LAL. The European Journal of Pharmaceutical Sciences published new research that challenged the recombinant alternatives to the LAL method, and the results from this study demonstrated that all recombinant products have a propensity to underpredict endotoxin activity when compared to gold standard, LAL.
Still considering evaluating an alternative endotoxin testing method? View the peer-reviewed research article, Evaluation of Limulus Amebocyte Lysate and Recombinant Endotoxin Alternative Assays for an Assessment of Endotoxin Detection Specificity.
Charles River’s QC microbiology testing portfolio brings you modern products and services that deliver accurate, relevant, and reliable data to allow you to make confident decisions on your product quality and contamination control. Our unique combination of Endosafe® endotoxin testing, Celsis® rapid microbial detection, and Accugenix® microbial identification and strain typing keeps your manufacturing operations running efficiently and smoothly, lowers your cost to manufacture, and protects your reputation.
This post is related to:
Quality Control/Analytical Testing
